Answer to Question 1
Correct Answer: 3
Rationale 1: The vaccine does not require the development of secondary sexual characteristics to be effective.
Rationale 2: The effectiveness of this vaccine is not dependent on other vaccines.
Rationale 3: The teen years are the most likely for the beginning of sexual contact.
Rationale 4: Side effects are not based on age.
Global Rationale: Spread through sexual contact, HPV infection may be asymptomatic or lead to the development of a low-grade infection that resolves spontaneously in individuals with a healthy immune system. A high-grade HPV infection may lead to the development of dysplasia, a precancerous change in the cervical cells that is directly related to the viral infection. The CDC recommends the routine vaccination of females 11 to 12 years old and of females ages 13 to 26 years who were not vaccinated at an earlier age. Females who have already been infected with a strain of HPV experience less benefit from vaccination. The vaccine does not depend upon puberty for effectiveness. It is not dependent upon previous vaccinations and the dosing schedule is not based upon side effects.
Answer to Question 2
Correct Answer: 1
Rationale 1: Pertussis immunization is started at age 2 months.
Rationale 2: A booster should be given at 46 years.
Rationale 3: The pertussis vaccine is given earlier than 2 years.
Rationale 4: A booster should be give at age 1518 months.
Global Rationale: Pertussis vaccine is always administered concurrently with the diphtheria and tetanus toxoids. The childhood vaccine is called DTaP. Children receive five intramuscular (IM) doses of DTaP, one dose at each of the following ages: 2 months, 4 months, 6 months, 15 to 18 months, and 4 to 6 years.